+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The clinical and muscular pathological features of statin-induced myopathy

The clinical and muscular pathological features of statin-induced myopathy

Zhonghua Nei Ke Za Zhi 54(8): 716-720

To explore clinical and muscular pathological features of statin-induced myopathy. Nine patients were enrolled in this study, who were diagnosed as statin-induced myopathy by muscle biopsy in Peking University First Hospital from April, 2012 to October, 2014. The clinical data and pathological findings were analyzed. The exposure time to statins varied from 4 days to 4 years in the total of 9 patients, 6 males and 3 females, with the average age of 63 ± 6 (55 to 74) years old. Three patients suffered from myalgia and 6 patients complained of weakness mainly at the proximal limbs, while no symptoms occured in 3 patients. Serum creatine kinase (CK) increased in all patients with the maximum value varied from 468 to 8 000 U/L. Serum myositis antibodies were tested in 7 patients and all were negative. Electromyogram was performed in six patients with myogenic damage found in 2 patients. MRI of bilateral thigh muscle was carried out in six patients with muscle edema and mild fatty infiltration found in 2 patients. All patients underwent skeletal muscle biopsy with histochemical and immunohistochemical staining. The main muscular pathological features were muscle fiber atrophy, necrosis, regeneration and increased lipid droplets. Ragged blue fiber, cytochrome C oxidase-negative muscle fibers and decreased NADH activity were observed in some patients. MHC-I expressed in the sarcolemma of muscle fibers at various levels. Mild C5b-9 staining was found in the endomysium, capillary and cytoplasm. Symptoms and the level of CK were improved in 7 patients after discontinuing statins or changing to another statin, while the immunosuppressive therapy were used in 2 patients and shown to be effective. Statin induced myopathy is self-limiting in most patients, with improvement after discontinuation of statins. Few patients with autoimmune necrotic myopathy need immunosuppressive therapy.

(PDF emailed within 1 workday: $29.90)

Accession: 059047132

Download citation: RISBibTeXText

PMID: 26674629

Related references

Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort. Clinical Rheumatology 37(2): 543-547, 2017

Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum". Autoimmunity Reviews 12(12): 1177-1181, 2014

Clinical analysis of 160 cases of statin-induced myopathy. Zhonghua Xin Xue Guan Bing Za Zhi 42(11): 905-909, 2015

Approach to clinical and genetic characterization of statin-induced myopathy. Methods in Molecular Biology 1175: 67-90, 2015

Clinical and pathological features of patients with nemaline myopathy. Molecular Medicine Reports 10(1): 175-182, 2015

Clinical, electrophysiological and pathological features of congenital myopathy. Journal of the Neurological Sciences 381: 1087-1088, 2017

Statin-induced myopathy: hypothesis about randomized evidence and clinical impressions. American Journal of Medicine 122(1): 4-5, 2009

NEB-related core-rod myopathy with distinct clinical and pathological features. Muscle & Nerve 53(3): 479-484, 2016

Myopathy With SQSTM1 and TIA1 Variants: Clinical and Pathological Features. Frontiers in Neurology 9: 147-147, 2018

Cystinosis distal myopathy, novel clinical, pathological and genetic features. Neuromuscular Disorders 27(9): 873-878, 2017

Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment. Journal of Pharmacy Practice 30(5): 521-527, 2016

Large copy-number variations in patients with statin-associated myopathy affecting statin myopathy-related loci. Physiological Research (): -, 2016

Diabetic cardio myopathy clinical hemodynamic and histo pathological features. Revue de Medecine Interne 3(2): 197-204, 1982

Clinical, pathological and immunohistological features of a case of localized nodular myopathy. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(5): 661-665, 1989

Myopathy with antibodies to the signal recognition particle: clinical and pathological features. Journal of Neurology, Neurosurgery, and Psychiatry 73(4): 420-428, 2002